The Laboratory tubes

Product

Factory wholesale Oxolinic acid - Pimobendan 74150-27-9 Metabolism PDE inhibitor – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

"Based on domestic market and expand overseas business" is our development strategy for Oxolinic acid 14698-29-4, Medetomidine hcl, 126828-32-8, Welcome to create the well and extensive standing business enterprise interactions with our business to produce a superb potential jointly. customers' pleasure is our eternal pursuit!
Factory wholesale Oxolinic acid - Pimobendan 74150-27-9 Metabolism PDE inhibitor – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Order (MOQ): 1g
Lead Time: 3 working days
Production capacity: 1kg/month
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial, bottle
Package size: 1g/vial, 5/vial, 10g/vial, 50g/bottle, 500g/bottle
Safety information:  UN 2811 6.1/PG 3

Pimobendan

Introduction

Pimobendan, is a veterinary medication. It is a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3) with positive inotropic and vasodilator effects.

Pimobendan is used in the management of heart failure in dogs, most commonly caused by myxomatous mitral valve disease (also previously known as endocardiosis), or dilated cardiomyopathy. Research has shown that as a monotherapy, pimobendan increases survival time and improves quality of life in canine patients with congestive heart failure secondary to mitral valve disease when compared with benazepril, an ACE inhibitor.

Specification (USP43)

Item

Specification

Appearance

White or slightly yellowish powder, hygroscopic

Mp

About 242℃

Solubility

Practically insoluble in water, freely soluble in dimethylformamide, slightly soluble in acetoneand in methanil.

Identification

Infrared absorption spectrophotometry, Comparison pimobendan CRS.

The retention time of the major peak of the Sample solution corresponds to that of the Standard stock solution,as obtained in the Organic Impurities test.

Heavy metals

≤10ppm

Granularity

P90 ≤ 25μ m

Particle size

20-80 mesh

Residual solvents

≤ 500ppm

Water

≤ 1.0%

Assay

98.0%~102.0%

Sulphated ash

≤ 0.10%

Related substances (HPLC)

impurity A

≤ 0.10%

impurity B

≤ 0.10%

Any other impurity

≤ 0.10%

Total impurity

≤ 0.20%


Product detail pictures:

Factory wholesale Oxolinic acid - Pimobendan 74150-27-9 Metabolism PDE inhibitor – Neore detail pictures


Related Product Guide:

Being supported by an state-of-the-art and skilled IT team, we could supply technical support on pre-sales & after-sales service for Factory wholesale Oxolinic acid - Pimobendan 74150-27-9 Metabolism PDE inhibitor – Neore , The product will supply to all over the world, such as: Ottawa, Hungary, Portland, Item have passed by means of the national qualified certification and been well received in our main industry. Our expert engineering team will often be ready to serve you for consultation and feedback. We have been able to also deliver you with cost-free samples to meet your specs. Ideal efforts will probably be produced to deliver you the most beneficial service and solutions. Should really you be interested in our company and solutions, please make contact with us by sending us emails or call us straight away. To be able to know our solutions and enterprise. ar more, you'll be able to come to our factory to see it. We will constantly welcome guests from all over the world to our firm. o build business enterprise. elations with us. You should feel absolutely free to speak to us for organization. nd we believe we are going to share the best trading practical experience with all our merchants.
  • As a veteran of this industry, we can say that the company can be a leader in the industry, select them is right.
    5 Stars By Lilith from Nairobi - 2017.04.18 16:45
    Perfect services, quality products and competitive prices, we have work many times, every time is delighted, wish continue to maintain!
    5 Stars By Joseph from Slovenia - 2017.09.30 16:36